Ombrato Luigi, Montagner Marco
Barts Cancer Institute, Queen Mary University of London, London, United Kingdom.
Department of Molecular Medicine, School of Medicine and Surgery, University of Padua, Padua, Italy.
Front Oncol. 2020 Nov 4;10:594514. doi: 10.3389/fonc.2020.594514. eCollection 2020.
Metastases are a major cause of cancer-related death and despite the fact that they have been focus of intense research over the last two decades, effective therapies for patients with distant secondary lesions are still very limited. In addition, in some tumor types metastases can grow years after the patients have been declared clinically cured, indicating that disseminated cancer cells (DCCs) persist undetected for years, even decades in a quiescent state. Clinical and experimental data highlight the importance of the immune system in shaping the fitness and behaviour of DCCs. Here, we review mechanisms of survival, quiescence and outgrowth of DCCs with a special focus on immune-regulation and we highlight the latest cutting-edge techniques for modelling the biology of DCCs and for studying the metastatic niche . We believe that a wide dissemination of those techniques will boost scientific findings towards new therapies to defeat metastatic relapses in cancer patients.
转移是癌症相关死亡的主要原因,尽管在过去二十年中它们一直是深入研究的焦点,但针对远处继发性病变患者的有效治疗方法仍然非常有限。此外,在某些肿瘤类型中,转移可在患者被宣布临床治愈数年之后出现,这表明播散性癌细胞(DCC)多年来一直未被检测到,甚至在静止状态下持续数十年。临床和实验数据凸显了免疫系统在塑造DCC的适应性和行为方面的重要性。在此,我们回顾DCC的存活、静止和生长机制,特别关注免疫调节,并强调用于模拟DCC生物学特性和研究转移微环境的最新前沿技术。我们相信,广泛传播这些技术将推动科学研究成果,以开发新疗法来战胜癌症患者的转移复发。